3098 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 13
10:19 UTC
|
PHVS
Pharvaris
|
↑ Upgrade | firm only | Overweight | |
|
Aug 13
10:19 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★☆☆☆ #2717 | Hold→ Buy | |
|
Aug 13
10:19 UTC
|
AMX
America Movil
|
↑ Upgrade | firm only | Neutral→ Outperform | |
|
Aug 13
08:19 UTC
|
ANNX
Annexon
|
↑ Upgrade | firm only | Underperform→ Market Perform | |
|
Aug 13
06:18 UTC
|
SM
SM Energy
|
↑ Upgrade | Hanwen Chang ★★★☆☆ #1602 | Equal Weight→ Overweight | $47.00 |
|
Aug 13
06:18 UTC
|
SLGN
Silgan
|
↑ Upgrade | Arun Viswanathan ★★★☆☆ #1917 | Sec→ r Perform ➝ Outperform | $58.00 |
|
Aug 13
00:18 UTC
|
YY
JOYY
|
↑ Upgrade | firm only | Buy | |
|
Aug 13
00:18 UTC
|
SMWB
Similarweb
|
↑ Upgrade | Luke Horton ★☆☆☆☆ #3026 | Market Perform→ Outperform | $5.00→ $10.00+100.0% |
|
Aug 13
00:18 UTC
|
SMMT
Summit Therapeutics
|
↑ Upgrade | Daina Graybosch ★★★★☆ #338 | Underperform→ Market Perform | $12.00→ $13.00+8.3% |
|
Aug 13
00:18 UTC
|
OKTA
Okta
|
↑ Upgrade | Rustam Kanga not yet tracked | Market Perform→ Outperform | $170.00 |
|
Aug 13
00:18 UTC
|
MRK
Merck & Co., Inc.
|
↑ Upgrade | firm only | Neutral→ Outperform | $143.00 |
|
Aug 13
00:18 UTC
|
JOYY
JOYY
|
↑ Upgrade | Daniel Chen not yet tracked | Neutral→ Overweight | $35.00→ $98.00+180.0% |
|
Aug 13
00:18 UTC
|
ISRG
Intuitive Surgical
|
↑ Upgrade | Suraj Kalia ★★★★★ #311 | Market Perform→ Outperform | $500.00 |
|
Aug 13
00:18 UTC
|
HLT
Hilton Worldwide
|
↑ Upgrade | firm only | Hold→ Buy | $365.00 |
|
Aug 13
00:18 UTC
|
GRWG
GrowGeneration
|
↑ Upgrade | Aaron Grey ★★★☆☆ #2177 | Neutral→ Buy | $2.50 |
|
Aug 13
00:18 UTC
|
ENTG
Entegris
|
↑ Upgrade | James Schneider ★★★☆☆ #1424 | Sell→ Buy | |
|
Aug 13
00:18 UTC
|
ENTG
Entegris
|
↑ Upgrade | Melissa Weathers ★★★☆☆ #1742 | Hold→ Buy | $152.00→ $200.00+31.6% |
|
Aug 13
00:18 UTC
|
AVAL
Grupo Aval Acciones y Valores
|
↑ Upgrade | firm only | Underweight→ Neutral | $5.50 |
|
Aug 12
19:17 UTC
|
SMMT
Summit Therapeutics
|
↑ Upgrade | Daina Graybosch ★★★★☆ #338 | Underperform→ Market Perform | $12.00→ $13.00+8.3% |
|
Aug 12
16:17 UTC
|
GRWG
GrowGeneration
|
↑ Upgrade | Aaron Grey ★★★☆☆ #2177 | Neutral→ Buy | $2.50 |
|
Aug 12
15:17 UTC
|
SMWB
Similarweb
|
↑ Upgrade | Luke Horton ★☆☆☆☆ #3026 | Market Perform→ Outperform | $5.00→ $10.00+100.0% |
|
Aug 12
15:17 UTC
|
JOYY
JOYY
|
↑ Upgrade | Daniel Chen not yet tracked | Neutral→ Overweight | $35.00→ $98.00+180.0% |
|
Aug 12
14:16 UTC
|
OKTA
Okta
|
↑ Upgrade | Rustam Kanga not yet tracked | Market Perform→ Outperform | $170.00 |
|
Aug 12
13:05 UTC
|
SMMT
Summit Therapeutics
|
↑ Upgrade | firm only | Underperform→ Market Perform | $13.00 |
|
Aug 12
13:05 UTC
|
OKTA
Okta
|
↑ Upgrade | firm only | Market Perform→ Outperform | $170.00 |
|
Aug 12
13:05 UTC
|
MRK
Merck & Co., Inc.
|
↑ Upgrade | firm only | Neutral→ Outperform | $143.00 |
|
Aug 12
13:05 UTC
|
JOYY
JOYY
|
↑ Upgrade | firm only | Neutral→ Overweight | $98.00 |
|
Aug 12
13:05 UTC
|
HLT
Hilton Worldwide
|
↑ Upgrade | firm only | Hold→ Buy | $365.00 |
|
Aug 12
13:05 UTC
|
GRWG
GrowGeneration
|
↑ Upgrade | firm only | Neutral→ Buy | $2.50 |
|
Aug 12
13:05 UTC
|
AVAL
Grupo Aval Acciones y Valores
|
↑ Upgrade | firm only | Underweight→ Neutral | $5.50 |
|
Aug 12
12:07 UTC
|
SMWB
Similarweb
|
↑ Upgrade | firm only | Market Perform→ Outperform | $10.00 |
|
Aug 12
12:07 UTC
|
ISRG
Intuitive Surgical
|
↑ Upgrade | Suraj Kalia ★★★★★ #311 | Market Perform→ Outperform | $500.00 |
|
Aug 12
12:07 UTC
|
ENTG
Entegris
|
↑ Upgrade | Melissa Weathers ★★★☆☆ #1742 | Hold→ Buy | $152.00→ $200.00+31.6% |
|
Aug 12
10:15 UTC
|
ENTG
Entegris
|
↑ Upgrade | James Schneider ★★★☆☆ #1424 | Sell→ Buy | |
|
Aug 12
10:15 UTC
|
ENTG
Entegris
|
↑ Upgrade | Melissa Weathers ★★★☆☆ #1742 | Hold→ Buy | $200.00 |
|
Aug 12
09:55 UTC
|
YY
JOYY
|
↑ Upgrade | firm only | Buy | |
|
Aug 12
09:55 UTC
|
ENTG
Entegris
|
↑ Upgrade | Melissa Weathers ★★★☆☆ #1742 | Hold→ Buy | |
|
Aug 12
00:54 UTC
|
TKNO
Alpha Teknova
|
↑ Upgrade | Mark Massaro ★★★★☆ #547 | Neutral→ Buy | $8.00 |
|
Aug 12
00:54 UTC
|
TIC
TIC Solutions
|
↑ Upgrade | Joshua Chan ★★★☆☆ #1354 | Neutral→ Buy | $11.00→ $12.50+13.6% |
|
Aug 12
00:54 UTC
|
SIA
Sienna Senior Living
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$25.00→ C$26.00+4.0% |
|
Aug 12
00:54 UTC
|
QMCO
Quantum
|
↑ Upgrade | Nehal Chokshi ★★★★☆ #830 | Market Perform→ Outperform | $24.00 |
|
Aug 12
00:54 UTC
|
P
Everpure
|
↑ Upgrade | Asiya Merchant ★★☆☆☆ #2306 | Neutral→ Buy | $90.00→ $118.00+31.1% |
|
Aug 12
00:54 UTC
|
JBL
Jabil
|
↑ Upgrade | David Vogt ★★★☆☆ #1509 | Neutral→ Buy | $430.00 |
|
Aug 12
00:54 UTC
|
IPHA
Innate Pharma
|
↑ Upgrade | firm only | Buy→ Outperform | |
|
Aug 12
00:54 UTC
|
IPHA
Innate Pharma
|
↑ Upgrade | firm only | Market Perform→ Outperform | $4.00 |
|
Aug 12
00:54 UTC
|
CODI
Compass Diversified
|
↑ Upgrade | Timothy D'Agostino ★★★★★ #256 | Neutral→ Buy | $11.00→ $15.00+36.4% |
|
Aug 12
00:54 UTC
|
CNC
Centene
|
↑ Upgrade | John Staszak ★★★☆☆ #1579 | Hold→ Buy | $80.00 |
|
Aug 12
00:54 UTC
|
CLBK
Columbia Financial
|
↑ Upgrade | Manuel Navas ★★★★★ #262 | Neutral→ Overweight | $19.00→ $14.00-26.3% |
|
Aug 12
00:54 UTC
|
CIB
Grupo Cibest
|
↑ Upgrade | Yuri Fernandes ★★★☆☆ #1005 | Neutral→ Overweight | $70.00→ $110.00+57.1% |
|
Aug 12
00:54 UTC
|
CFW
Calfrac Well Services
|
↑ Upgrade | firm only | Sec→ r Perform ➝ Outperform | C$7.50→ C$9.00+20.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.